EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Circular RNAs in Cardiac Fibrosis: Mechanisms and Therapeutic Implications

Toufik Abdul-Rahman iD, Mrinmoy Kundu, Poulami Roy, Jann Ludwig Mueller-Gomez iD, Aditya Gaur iD, Mohammad Alabdulrahman iD, Hala Ibrahim Thaalibi iD, Syeda Asna Shireen Munawer iD, Emmanuella Ifeoma Okonkwo iD, Ayaan Hassan Mohamed, Riddhi Mondal iD, Rakhshanda Khan iD und 4 weitere

Clinical Cardiology · 2026-11 · 49 (11)

DOI: 10.1002/clc.70502 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Cardiology, online erschienen am 13.11.2026. Verfasst von Toufik Abdul-Rahman und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research, Toufik's World Medical Association, Sumy, Ukraine. Hauptthemen laut MEDLINE: RNA, Circular, Myocardium, Gene Expression Regulation. Die Arbeit nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiac fibrosis, characterized by excessive extracellular matrix (ECM) deposition, contributes to adverse cardiac remodeling and heart failure. Circular RNAs (circRNAs) have emerged as regulators of fibrotic processes, with potential applications in cardiovascular diagnosis and therapy. This review examines the molecular mechanisms through which circRNAs regulate cardiac fibrosis and evaluates their potential as diagnostic biomarkers and therapeutic targets.

Methods

A comprehensive literature search was conducted using PubMed and Scopus to identify studies investigating the roles of circRNAs in cardiac fibrosis, including their molecular mechanisms, diagnostic potential, and therapeutic applications. Relevant experimental and clinical studies were examined.

Results

Experimental evidence implicates circRNAs in cardiac fibroblast activation, myofibroblast differentiation, and ECM remodeling through microRNA‐mediated regulation and interactions with profibrotic signaling pathways, including TGF‐β/SMAD and Wnt/β‐catenin. circSMAD4, circHelz, and circHIPK3 have been associated with profibrotic responses, whereas circNFIB and circCDR1 have demonstrated antifibrotic effects in experimental models. Modulation of circRNA expression has attenuated fibrosis and improved cardiac function in selected animal studies. The structural stability and tissue‐specific expression of circRNAs also support their investigation as potential circulating biomarkers. However, clinical evidence remains limited, and therapeutic translation faces challenges related to targeted delivery, off‐target effects, immunogenicity, and tissue specificity.

Conclusions

CircRNAs are important regulators of cardiac fibrosis and represent promising candidates for diagnostic biomarker development and targeted antifibrotic therapy. Despite encouraging preclinical findings, further clinical research is needed to establish their diagnostic validity, safety, and therapeutic efficacy in humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, CircularMyocardiumGene Expression RegulationHumansFibrosisAnimalsBiomarkersSignal Transduction

Stichwörter der Autor:innen

cardiac fibrosiscircularRNAsdiagnostic biomarkerstherapeutic targets

Substanzen

RNA, CircularBiomarkers

Autor:innen und Institutionen

  • Department of Research, Toufik's World Medical Association, Sumy, Ukraine.
  • Institute of Medical Sciences and SUM Hospital, Bhubaneswar, India.
  • Department of Medicine, North Bengal Medical College and Hospital, Siliguri, India.
  • Center for Research in Health Sciences (CICSA), Faculty of Medicine, Anahuac University North Campus, Huixquilucan, Mexico.
  • Yeovil District Hospital, Somerset NHS Foundation Trust, Yeovil, UK.
  • Department of Surgery, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

ORCID-Profile: Toufik Abdul-Rahman, Jann Ludwig Mueller-Gomez, Aditya Gaur, Mohammad Alabdulrahman, Hala Ibrahim Thaalibi, Syeda Asna Shireen Munawer, Emmanuella Ifeoma Okonkwo, Riddhi Mondal, Rakhshanda Khan, Bibek Shrestha, Enaholo Tobechukwu Mathew Olumese, Carl J Lavie, Rahul Gupta

Zitieren

APA

Abdul-Rahman, T., Kundu, M., Roy, P., Mueller-Gomez, J. L., Gaur, A., Alabdulrahman, M., Thaalibi, H. I., Munawer, S. A. S., Okonkwo, E. I., Mohamed, A. H., Mondal, R., Khan, R., Shrestha, B., Olumese, E. T. M., Lavie, C. J., & Gupta, R. (2026). The Role of Circular RNAs in Cardiac Fibrosis: Mechanisms and Therapeutic Implications. Clinical Cardiology, 49(11). https://doi.org/10.1002/clc.70502

Vancouver

Abdul-Rahman T, Kundu M, Roy P, Mueller-Gomez JL, Gaur A, Alabdulrahman M, et al. The Role of Circular RNAs in Cardiac Fibrosis: Mechanisms and Therapeutic Implications. Clinical Cardiology. 2026;49(11). doi:10.1002/clc.70502

BibTeX
@article{AbdulRahman2026,
  author = {Abdul-Rahman, Toufik and Kundu, Mrinmoy and Roy, Poulami and Mueller-Gomez, Jann Ludwig and Gaur, Aditya and Alabdulrahman, Mohammad and Thaalibi, Hala Ibrahim and Munawer, Syeda Asna Shireen and Okonkwo, Emmanuella Ifeoma and Mohamed, Ayaan Hassan and Mondal, Riddhi and Khan, Rakhshanda and Shrestha, Bibek and Olumese, Enaholo Tobechukwu Mathew and Lavie, Carl J and Gupta, Rahul},
  title = {The Role of Circular RNAs in Cardiac Fibrosis: Mechanisms and Therapeutic Implications},
  journal = {Clinical Cardiology},
  year = {2026},
  volume = {49},
  number = {11},
  doi = {10.1002/clc.70502}
}
Kostenlos starten →